Manufacturers have focused on reducing complications related to these devices.
The neurovascular thrombectomy devices market in the Asia Pacific is projected to grow at a compound annual growth rate (CAGR) of about 6% between 2020 and 2025, amidst technological advancements improving its successful and safe use, according to a report from GlobalData.
“Medical device manufacturers have focussed on reducing procedural complications related to these devices, thereby increasing the number of procedures performed,” GlobalData's medical devices analyst Minith Kumar commented.
Kumar noted that these technologies can help reduce procedure times, improve revascularization rates and translate to better functional outcomes for patients. Thus, more number of thrombectomy procedures are expected to be made in the region going forward.
“The innovative stent retrievers and aspiration catheters represent the next generation of technology designed to improve neurovascular thrombectomy procedures’ success rates,” Kumar said.
In 2019, Japan accounted for about 65% of the region's neurovascular thrombectomy devices market, followed by South Korea and China, which together contributed about 27%.
The report noted that the adoption of thrombectomy devices varies from country to country in the region. The growth is significant in developed countries such as Japan, South Korea, and Australia due to their better and advanced healthcare infrastructure.
However, in developing countries such as India, the growth is currently less due to fewer centers performing these procedures and less number of specialists available.
Do you know more about this story? Contact us anonymously through this link.